Here is a clear interpretation of this Brain MRI with Contrast + MR Spectroscopy (Multi-Voxel) + Whole Spine Screening report for patient Anita Kumari, F/52y, scanned 16-05-2026.
π§ Brain MRI with Contrast β Key Findings
1. The Main Concern: A Right Frontal Lobe Lesion
The most significant finding is a large, heterogeneously enhancing intra-axial (within the brain substance) lesion in the right frontal lobe, with extension into:
- The right gangliocapsular region (basal ganglia area)
- The left insular region
- Left frontal deep white matter, middle frontal gyrus, and left middle frontal area
"Intra-axial" = the lesion is within the brain tissue itself (not a surface/meningeal lesion).
"Heterogeneously enhancing" = the lesion lights up unevenly with contrast dye, which is a concerning feature.
2. MR Spectroscopy Result
The spectroscopy (a metabolic "chemical fingerprint" of the lesion) showed:
- Normal NAA peak and normal Cho:Cr ratio β No increased perfusion
This is a critically important reassuring finding. In aggressive brain tumors (like glioblastoma), you'd expect an elevated Cho:Cr ratio (high choline = rapid cell turnover) and reduced NAA. The normal spectroscopy argues against a high-grade primary brain tumor (like GBM).
3. Background Brain Changes
- Diffuse cerebral atrophy (brain shrinkage) with cortical sulcal prominence, sylvian fissure widening, and basal cistern enlargement β consistent with age-related or chronic changes for a 52-year-old.
- Few punctate and confluent T2/FLAIR hyperintense foci in bilateral periventricular and deep white matter β Chronic microangiopathic ischemic changes (small vessel disease, commonly from hypertension, diabetes, high cholesterol, or smoking).
- Frontoparietal white matter T2/FLAIR signal changes also consistent with this small vessel disease pattern.
- Corpus callosum appears normal.
- No acute infarct.
- Pituitary gland, brainstem, cerebellum, and hypothalamic region β all unremarkable (normal).
- No extra-axial collection. No abnormal vascular flow voids.
𦴠Whole Spine Screening (Contrast)
- Mild multilevel degenerative/spondylotic changes in the cervical and lumbar spine β these are age-appropriate wear-and-tear changes (disc problems, bone spurs).
- Mild desiccative changes in the cervical and lumbar discs.
- No abnormal enhancing vertebral marrow lesion β No spread of disease (e.g., no metastases) to the spine.
- No leptomeningeal (surface coating of spinal cord) or intradural enhancement.
- Paranasal sinuses and orbits are unremarkable.
π¬ Radiologist's Impression & Differentials
The radiologist lists the following possible diagnoses for the frontal lobe lesion:
| Priority | Differential Diagnosis | Why |
|---|
| 1st | Tumefactive demyelination | Large lesion with incomplete/ring enhancement, low perfusion, elevated ADC (water diffusion), less mass effect β classic features |
| 2nd | Multi-focal, multi-territory demyelination (e.g., MS or similar) | Multi-focal, bilateral involvement |
| 3rd | Central vein traversing enhancement | A vein-centered pattern typical of demyelination |
| 4th | Neoplastic etiology | e.g., lymphoma or glioma β but less likely given: elevated ADC, less mass effect, normal spectroscopy |
What is "Tumefactive Demyelination"?
This is a large, tumor-mimicking demyelinating plaque β essentially a form of MS (or related condition) where the immune system attacks the myelin sheath of nerve fibers, creating a lesion so large it looks like a tumor on imaging. The normal MR spectroscopy strongly supports this over a true tumor.
π Background Finding: Chronic Microangiopathic Changes
The diffuse cerebral atrophic changes with white matter signal alterations suggest chronic small vessel ischemic disease β consistent with long-standing vascular risk factors. This is a separate background finding from the main frontal lesion.
π©Ί What Does the Radiologist Recommend?
"Advice: Close follow-up and histopathological correlation"
This means:
- The imaging alone cannot definitively distinguish between a tumefactive demyelinating lesion and a neoplastic (tumor) process.
- The patient may need a brain biopsy (tissue sample) to get a definitive diagnosis.
- Alternatively, clinical correlation (patient's symptoms, history, other investigations like CSF analysis, oligoclonal bands, VEPs) may guide management.
β οΈ Summary in Plain Language
Your radiologist found a large, abnormal area in the right side of the brain that could be either:
- A non-cancerous inflammatory/immune condition (tumefactive MS β most likely given the spectroscopy), or
- A brain tumor (less likely but cannot be ruled out)
The good news is that the metabolic fingerprint (MR spectroscopy) does not look like a typical aggressive cancer. However, this report cannot be the final word β a neurologist and/or neurosurgeon should review this urgently and decide whether a biopsy or further investigations (like CSF analysis, repeat MRI in a few weeks, PET scan) are needed.
This report should be reviewed promptly by a neurologist. Do not delay seeking a specialist opinion.